Rivastigmine transdermal compositions are provided. Aspects of the transdermal compositions include an active agent layer which includes rivastigmine and a solubility modulator, e.g., crosslinked acrylic acid polymer. Also provided are methods of using the transdermal compositions and kits containing the transdermal compositions.本發明係提供里曼提明(Rivastigmine)經皮組成物。經皮組成物之態樣包括一活性劑層,其包括里曼提明及溶解度調節劑,如經交聯之丙烯酸聚合物。本發明亦提供使用經皮組成物之方法及含有經皮組成物之套組。
